Skip to main content
Tango Therapeutics, Inc. logo

Tango Therapeutics, Inc. — Investor Relations & Filings

Ticker · TNGX ISIN · US87583X1090 US Professional, scientific and technical activities
Filings indexed 355 across all filing types
Latest filing 2025-11-14 Major Shareholding Noti…
Country US United States of America
Listing US TNGX

About Tango Therapeutics, Inc.

https://www.tangotx.com/

Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering and developing a new generation of precision oncology medicines. The company's approach is centered on the principle of synthetic lethality, a genetic strategy to target cancer vulnerabilities. By utilizing its proprietary drug discovery platform, which integrates CRISPR technology, Tango identifies novel drug targets and develops therapies for genetically defined patient populations with unmet medical needs. The company's pipeline is designed to deliver transformative medicines that take direct aim at specific tumors, with the goal of expanding the reach of genetically targeted cancer therapies.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-14 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-13 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-12 English
4
Director's Dealing
2025-11-04 English
8-K
Regulatory Filings
2025-11-04 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.